H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 141 Citations 76,532 1,645 World Ranking 635 National Ranking 4

Research.com Recognitions

Awards & Achievements

Member of the European Academy of Sciences and Arts

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

The scientist’s investigation covers issues in Bladder cancer, Surgery, Urology, Internal medicine and Cystectomy. His studies in Bladder cancer integrate themes in fields like Urinary bladder, Carcinoma in situ, Pathology, Cystoscopy and Stage. His Surgery study integrates concerns from other disciplines, such as Prostatectomy, Prostate cancer, Nomogram and Hazard ratio.

His studies deal with areas such as Cancer, Lymphovascular invasion, Transitional cell carcinoma, Lymph node and Carcinoma as well as Urology. His research in Internal medicine intersects with topics in Gynecology and Oncology. His Cystectomy research is multidisciplinary, relying on both Perioperative, Lymphadenectomy and Urothelial carcinoma.

His most cited work include:

  • EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. (1390 citations)
  • Epidemiology and risk factors of urothelial bladder cancer (1002 citations)
  • EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 (845 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Urology, Oncology, Bladder cancer and Cystectomy. His work on Prostate cancer, Proportional hazards model, Nephrology and Disease as part of general Internal medicine research is frequently linked to In patient, bridging the gap between disciplines. His study in Urology is interdisciplinary in nature, drawing from both Prostatectomy, Stage, Surgery, Carcinoma and Urothelial carcinoma.

His biological study spans a wide range of topics, including Upper tract, Meta-analysis, Chemotherapy and Survival rate. Concomitant is closely connected to Carcinoma in situ in his research, which is encompassed under the umbrella topic of Bladder cancer. His Cystectomy research incorporates elements of Urinary bladder, Lymphadenectomy, Lymphovascular invasion and Dissection.

He most often published in these fields:

  • Internal medicine (62.54%)
  • Urology (44.46%)
  • Oncology (43.57%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (62.54%)
  • Bladder cancer (39.39%)
  • Oncology (43.57%)

In recent papers he was focusing on the following fields of study:

Shahrokh F. Shariat mostly deals with Internal medicine, Bladder cancer, Oncology, Urology and Prostate cancer. In general Internal medicine study, his work on Meta-analysis, Hazard ratio, Epidemiology and Renal cell carcinoma often relates to the realm of In patient, thereby connecting several areas of interest. Shahrokh F. Shariat studies Bladder cancer, focusing on Cystectomy in particular.

His research investigates the connection with Oncology and areas like Nivolumab which intersect with concerns in Ipilimumab. The various areas that he examines in his Urology study include Stage, Proportional hazards model, Urothelial carcinoma and Lymph node. His Prostate cancer research includes elements of Prostate and Radiation therapy.

Between 2019 and 2021, his most popular works were:

  • EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort† (36 citations)
  • Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial (28 citations)
  • Risk Stratification Tools and Prognostic Models in Non–muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel (27 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

Shahrokh F. Shariat spends much of his time researching Internal medicine, Bladder cancer, Oncology, Cystectomy and Urology. Shahrokh F. Shariat interconnects Clinical trial, Epidemiology, Carcinoma, Disease and Stage in the investigation of issues within Bladder cancer. His Oncology research integrates issues from Pembrolizumab, Randomized controlled trial, Combination therapy and Chemotherapy.

His biological study spans a wide range of topics, including Odds ratio, Urinary bladder, Cumulative incidence, Perioperative and Radiation therapy. His Urology research includes elements of Carcinoma in situ, Guideline, Upper tract, Urothelial carcinoma and Concomitant. His research in Hazard ratio intersects with topics in Lower risk and Proportional hazards model.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Epidemiology and risk factors of urothelial bladder cancer

Maximilian Burger;James W.F. Catto;Guido Dalbagni;H. Barton Grossman.
European Urology (2013)

1605 Citations

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Marko Babjuk;Andreas Böhle;Maximilian Burger;Otakar Capoun.
European Urology (2017)

1445 Citations

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

Marko Babjuk;Maximilian Burger;Richard Zigeuner;Shahrokh F. Shariat.
European Urology (2013)

1320 Citations

Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

Vitaly Margulis;Shahrokh F. Shariat;Surena F. Matin;Ashish M. Kamat.
Cancer (2009)

814 Citations

Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy

Andrew J. Stephenson;Shahrokh F. Shariat;Michael J. Zelefsky;Michael W. Kattan.
JAMA (2004)

714 Citations

Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research Consortium

Shahrokh F. Shariat;Pierre I. Karakiewicz;Ganesh S. Palapattu;Yair Lotan.
The Journal of Urology (2006)

710 Citations

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

Morgan Rouprêt;Marko Babjuk;Eva Compérat;Richard Zigeuner.
European Urology (2015)

670 Citations

European guidelines on upper tract urothelial carcinomas: 2013 update.

Morgan Rouprêt;Marko Babjuk;Eva Compérat;Richard Zigeuner.
European Urology (2013)

496 Citations

Systematic Review and Meta-analysis of Studies Reporting Oncologic Outcome After Robot-assisted Radical Prostatectomy

Giacomo Novara;Vincenzo Ficarra;Simone Mocellin;Thomas E. Ahlering.
European Urology (2012)

473 Citations

Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy

Giacomo Novara;Vincenzo Ficarra;Raymond C. Rosen;Walter Artibani.
European Urology (2012)

461 Citations

Editorial Boards

Current Opinion in Urology
(Impact Factor: 2.808)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Shahrokh F. Shariat

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 285

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 244

Quoc-Dien Trinh

Quoc-Dien Trinh

Brigham and Women's Hospital

Publications: 215

Pierre I. Karakiewicz

Pierre I. Karakiewicz

University of Montreal

Publications: 195

Markus Graefen

Markus Graefen

Universität Hamburg

Publications: 164

Morgan Rouprêt

Morgan Rouprêt

Université Paris Cité

Publications: 162

Yair Lotan

Yair Lotan

The University of Texas Southwestern Medical Center

Publications: 157

Ashish M. Kamat

Ashish M. Kamat

The University of Texas MD Anderson Cancer Center

Publications: 130

Stephen A. Boorjian

Stephen A. Boorjian

Mayo Clinic

Publications: 127

Liang Cheng

Liang Cheng

Indiana University

Publications: 122

Maxine Sun

Maxine Sun

Brigham and Women's Hospital

Publications: 117

Felix K.-H. Chun

Felix K.-H. Chun

Universität Hamburg

Publications: 115

Rodolfo Montironi

Rodolfo Montironi

Marche Polytechnic University

Publications: 113

Mani Menon

Mani Menon

Henry Ford Hospital

Publications: 110

Arnulf Stenzl

Arnulf Stenzl

University of Tübingen

Publications: 106

Antonio Lopez-Beltran

Antonio Lopez-Beltran

University of Córdoba

Publications: 102

Something went wrong. Please try again later.